A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis

Category Primary study
JournalJournal of Hepatology
Year 2022
This article has no abstract
Epistemonikos ID: abcc230fccecddf029468b8db8c535d8cddd8ff1
First added on: Feb 14, 2025